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1. Introduction 
Rats (Rattus norvegicus) have been used more extensively than mice in the research fields of 
neuroscience, pharmacology and toxicology. There are more than 100 rat strains with 
various genetic backgrounds, including some useful models for human diseases. For 
example, the SHR (spontaneously hypertensive rat) strain and the BB (rats spontaneously 
developing insulin-dependent diabetes mellitus) strain are well-established models for 
studying cardiovascular diseases and endocrinopathy (Okamoto, 1969; Like et al., 1982). 
Because of the well-understood mapping of brain functions, rats are often used for 
physiological studies on memory and emotion (Wood et al., 1999; van Erp et al., 2000). 
Furthermore, experimental studies on mammary tumors require the use of rats in which 
symptoms of the disease are distinct from those caused by mouse mammary tumor viruses; 
mouse mammary tumor viruses cause tumors in the mammary glands of mice but not those in 
humans or rats (Carr et al., 1981; Gould, 1986). In addition, transgenic rats have been used as 
model animals for human diseases (e.g., Alzheimer’s disease, autoimmunity and high-density 
lipoprotein [HDL] metabolism) and organ transplantation, and as animal bioreactors for 
protein production (Heideman, 1991; Charreau et al., 1996; Ganten, 1998). One advantage of 
using rats rather than mice in transgenic studies is the ease of continuous or repeated sample 
collection (e.g., of blood or urine) and surgery, due to their larger size, while litter size, 
gestation length, maturation rate, estrous cycle length, and life span of rats are all very similar 
to those of mice. Thus, the rat has the advantage of being a reasonably well-characterized and 
intermediate-sized rodent that can be maintained much more cheaply than larger animals and 
can often be manipulated much more easily than smaller rodents. 
On the other hand, the reverse genetic approach using the rats (precise and conditional gene 
replacements [knock-in] or loss of gene function [knock-out] at the specific locus) was 
considered impossible because any protocols to establish embryonic stem (ES) cell lines 
conventionally used in mice were not applicable to the rats. However in 2008, functional 
germline-competent ES cell lines have been reported (Buehr et al., 2008; Li et al., 2008). Very 
recently, successful production of p53 gene knock-out rats by homologous recombination in 
the ES cells has been achieved at last (Tong et al., 2010). The present chapter deals with an 
overview of attempts at producing gene-modified rats (with or without using ES cells), 
followed by detailed protocols for establishment of rat ES cell lines, and for successful use of 
the rat ES cells in transgenesis via electroporation (Hirabayashi et al., 2010a; 2010b).  
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2. Approaches to produce gene-modified rats 
Transgenic rats integrated with foreign gene into their genomes can be routinely produced 
by conventional pronuclear microinjection (Hammer et al., 1990; Hochi et al., 1990; Mullins 
et al., 1990) or by an intracytoplasmic sperm injection (ICSI)-mediated gene transfer protocol 
(Kato et al., 2004; Hirabayashi et al., 2005). As for production of rats genetically modified 
(knock-in or knock-out of endogenous gene function), the most convenient tool, ES cell line, 
was not available for this rodent. Despite of numerous efforts, all attempts at establishing rat 
ES cell lines have resulted in total failures (Brenin et al., 1997; Vassilieva et al., 2000; Buehr et 
al., 2003); some ES-like cell lines have been derivated, but phenotype of the ES-like cell 
origin was not contributed to chimera or was not transmitted to G1 generation offspring, 
even though they could proliferate while maintaining undifferentiated status and show 
multipotency under certain conditions for inducing differentiation. Ueda et al. (2008) 
reported the production of chimeric rats derived from blastocyst injection of transgenic ES 
cells (established by classical method), without data for germline transmission of the 
exogenous gene. 
Therefore alternatively, sophisticated approaches were used to induce genetic mutations in 
the rats. Gene-modified rats have been successfully produced by the following three 
approaches. (1) The yeast-based screening assay of N-ethyl-N-nitrosourea (ENU) mutated 
G1 offspring (Zan et al., 2003; Chen & Gould, 2004) allows to produce serial allelic variations 
of targeted genes, in addition to knock-out mutants expected. In another words, targeted 
gene modifications at the specific locus (Scn1a; a missense mutantion presumptively 
responsible to epilepsy) are difficult to achieve in the ENU-mutagenesis (Mashimo et al., 
2008). (2) Sleeping beauty (SB) transposon system was found effective to induce insertional 
mutatation in rats (Kitada et al., 2007) as well as in mice (Keng et al., 2005). This system 
includes the production of two independent transgenic lines carrying the SB transposon 
vector (eqipped with promoter trap system and poly-[A] trap system) and SB transposase, 
respectively, and the subsequent interline coupling to produce double-transgenic rats. 
Transposition events occurs not only on the same chromosome but also between different 
chromosomes. This SB transposon-tagged mutagenesis is disadvantageous in controlling the 
frequency of mutation at the specific locus, too. (3) Zinc-finger nucleases (ZFNs) can create 
genome-specific double-stranded breaks and therefore more likely to induce targeted gene 
mutation. Microinjection of DNA or mRNA that encodes specific ZFNs into pronuclear 
zygotes derived from green fluorescent protein (GFP) transgenic rats resulted in a high 
frequency of rat offspring that do not express the transgenic marker, due to a consequence 
of homologous recombination at the GFP locus (Geurts et al., 2009). Mutation in rat genome 
has been induced in interleukin 2 receptor gamma (IL2rγ) locus by this approach (Mashimo 
et al., 2010). One of the obstacles in the ZFNs technology is the difficult customization of the 
DNA/mRNA motif for ZFNs specific to the desired locus. 
Cloning by somatic cell nuclear transplantation (SCNT) is an alternative approach to 
produce gene-modified rats. Successful production of cloned rats with somatic cells was first 
reported by Zhou et al. (2003). However, the reproducibility of the data is still questionable 
(Hirabayashi & Hochi, 2006). As to reasons why rat SCNT is difficult, rat oocytes are likely 
to activate spontaneously in vitro after recovery from the oviductal ampullae (Zernicka-
Goetz, 1991; Ito et al., 2005). The male germline stem (GS) cell line, which is capable of 
culturing and differentiating in vitro, is also a source of cells for gene targeting and 
production of knockout animals via ICSI or other microinsemination techniques (Feng et al., 
2002; Toyooka et al., 2003; Geijsen et al., 2004). When rat spermatogonial stem cells were 
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transplanted into busulfan-treated nude mouse testes, microinsemination of the retrieved 
rat spermatids and spermatozoa into rat oocytes resulted in viable rat offspring (Shinohara 
et al., 2006). The SCNT/GS cell technologies combined with homologous recombination-
based gene targeting will become a powerful tool for production of knock-out rats, once 
they can be established and widespread.  
Breakthrough in establishing rat ES cell lines was appeared at the end of 2008 year (26th 
December, 2008). Functional germline-competent ES cell lines have been reported by using a 
few inhibitors for fibroblast growth factor (FGF) receptor, mitogen activated protein kinase 
kinase (MEK) and glycogen synthase kinase 3 (GSK3) in differentiation-related signaling 
pathways (Buehr et al., 2008; Li et al., 2008). This protocol, the so-called 3i/2i culture system, 
was originated from ES cell research in mouse (Ying et al., 2008) and was proved 
reproducible even after slight modificatons were added to the culture system (Hirabayashi 
et al., 2010a; Kawamata & Ochiya, 2010). The modification made by Hirabayashi et al. 
(2010a) is to replace MEK activation inhibitor PD1843521 with MEK inhibitor PD325901 and 
to add rat leukemia inhibitory factor (LIF) instead of LIF-secreting feeder cells in the 3i 
system, while that made by Kawamata & Ochiya (2010) is to add fetal bovine serum (FBS), 
ß-mercaptoethanol, rat LIF, and inhibitors for Rho-associated coiled-coil kinase (ROCK) and 
transforming growth factor-beta (TGF-ß) type-I receptor ALK5 kinase to the 2i culture 
medium containing MEK and GSK3 inhibitors. Very recently, successful production of p53 
gene knock-out rats by homologous recombination in the ES cells has been achieved (Tong 
et al., 2010). The p53 is tumour suppressor gene located on rat chromosome 10, and 
mutations in the p53 gene are highly associated with genetic lesions in human cancers. Soon 
or later, the homologous recombination-based gene targeting in rat ES cell lines will allow 
for practical production and analysis of individual rats with targeted mutation in every 
research fields, as routinely done in mice.  
3. Establishment of rat ES cells 
Development of a methodology for reverse genetic research has been long desired, because 
the rat is the most widely used animal model in biological research. The most convenient 
method for production of knockout rats is to use gene-targeted ES cells in germline chimera 
production. Although rat ES cell lines have not been established despite of numerous 
efforts, recent application of 2i/3i culture system enabled the derivation of germline-
competent rat ES cell lines (Buehr et al., 2008; Li et al., 2008). In this section, rat ES cell lines 
that can participate in germline chimeras at high efficiency (Hirabayashi et al., 2010a; with a 
few additional data) are described. 
3.1 Isolating undifferentiated colonies from blastocysts  
Blastocysts at E4.5 (E0 was defined as the initiation of coupling) were recovered by uterine 
flushing of Wistar females couplated with a homogenous CAG/venus transgenic male rat. 
Green fluorescence of the venus gene was used as the transgenic marker. Their zonae 
pellucidae were removed in acid tyrodes solution (5 sec at an ambient temperature), and 
then each blastocyst was placed on mitomycin (MMC)-treated mouse embryonic fibroblasts 
(MEF; concentraton of the feeder cells, 3 to 4 x 105 cells/ml; see below note-1) in a well of 4-
well dish. The culture medium consisted of 2 µM FGF receptor inhibitor, SU5402 
(Calbiochem), 1 µM MEK inhibitor, PD0325901 (Stemgent), 3 µM GSK3 inhibitor, 
CHIR99021 (Axon), and 1,000 U/ml rat LIF (ESGRO®, Millipore) in N2B27 medium (see 
below note-2). After 7 days culture at 37˚C in a humidified atmosphere of 5% CO2 in air, the 
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outgrowths of the blastocysts (Fig. 1a) were disaggregated by gentle pipetting and 
transferred to the same MEF/3i conditions (first passage). However, time required until the 
first passage (5 days to 2 weeks) may depend on rat strains for blastocysts. When ES cell-like 
colonies were emerged (Fig. 1b), they were trypsinized in 0.25% trypsin/0.6 mM EDTA 
solution (Sigma) and then expanded (Fig. 1c). The tentative ES cell lines were maintained in 
MEF/3i conditions, with medium exchange every other day and trypsinization/expansion 
(passage) every three days. Otherwise, the ES cell lines were cryopreserved to prevent 
senescence (see below note-3). It was checked whether the derivated cells are alkaline 
phosphatase (AP)-positive (Fig. 1d). Nine ES cell lines (69.2%) were established from 13 
transgenic blastocysts. Among them, two lines with excellent growth rate (rESWIv3i-1 and 
rESWIv3i-5) were selected, and both lines were found female by PCR analysis to detect rat 
Sry gene. Attachment of ES cell colonies with the feeder cells was not so strong, and 
morphological appearance of the rat ES cell colonies was similar to that of mouse ES cells. 
As the passage number of the ES cells increased, signs of differentiation into extraembryonic 
cell-like cells were observed in cultures, especially when the culture medium was exchanged 
every other day rather than every day (Fig. 1e and 1f).      
 
 
Fig. 1. Establishment of rat ES cell line. (a) Outgrowth of a blastocyst on MEF feeders 7 days 
after plating. (b) Formation of colonies 3 days after the first passage. (c) Expanded ES cell 
colonies 2 days after fourth passage. (d) Alkaline phosphatase-positive colony at passage 12. 
(e) The ES cells at passage 17. Under the daily exchange of culture medium, very little cells 
showed any signs of differentiation. (f) The ES cells at passage 17, maintained with medium 
exchange every other day. Differentiated extra-embryonic cells were observed. Scale bars: a, 
d, e and f; 100-µm, b and c; 500-µm 
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Notes: (1) MEF Preparation; One-ml of neomycin (G418)-resistant MEF cell cryostock (2 to 3 
x 107 cells/vial, Kitayama Labes) were thawed in 37˚C waterbath, and resuspended in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS (ES cell 
qualified). The cell suspension was centrifuged for 190 x g for 5 min at 4˚C, resuspended in 
DMEM/10% FBS, and then cultured for 2 to 3 days. Confluently proliferated cells were 
liberated by trypsin/EDTA treatment, centrihuged for 190 x g for 5 min at 4˚C, resuspended, 
and replated (passage). After several passages, the cells were treated with 10 µg/ml MMC 
for 2 h at 37˚C in 5% CO2 in air. After washing twice by centrifugation, the MCC-treated 
MEFs were used as the feeder cells. The DMEM and FBS were purchased from Gibco. (2) 
N2B27 medium; A 1:1 mixture of DMEM/F12 (1:1) and Neurobasal medium was 
supplemented with B-27 serum-free supplement, N-2 serum-free supplement, 2 mM L-
glutamine, 50 U/ml penicillin, and 50 mg/ml streptomycin. Media and reagents for N2B27 
medium were all purchased from Gibco. (3) Cryopreservation of ES cells; ES cells were 
liberated by the trypsin/EDTA treatment for 5 min at 37˚C in 5% CO2 in air, and were 
collected in a 15 ml conical tube after gentle pipetting. After centrifugation for 190 x g for 5 
min at 4˚C, the cell pellet was resuspended with 1 ml of CellBanker®. The cryovials (1 x 106 
cells/ml/cryovial) were transferred into a BICELL®, and kept overnight in a –80˚C deep-
freezer. The cryovials were then stored in a liquid nitrogen tank until use. 
3.2 Confirmation of characteristics essential for ES cells  
In addition to AP activity of the tentative ES cells (Fig. 1d), expression of stem cell marker 
genes, such as Oct-4, Nanog, Fgf-4, or Rex-1, should be confirmed by reverse transcription 
(RT)-PCR analysis. Each primer sets were designed as shown in Table 1. Total RNA was 
prepared using the RNeasy mini Kit (Qiagen), and the RT-PCR was performed using the 
SuperScript™III One-Step RT-PCR System with Platinum®Taq High Fidelity kit 
(Invitrogen™), with the reaction conditions for cDNA synthesis (55°C for 30 min and 94°C 
for 2 min) and amplification (30 cycles at 94°C for 15 sec, 55°C for 30 sec, and 68°C for 60 
sec). As shown in Fig. 2, both rESWIv3i-1 and rESWIv3i-5 lines expressed Oct-4, rNanog, 
Fgf-4 and Rex-1, indicating that these cell lines had undifferentiated characteristics. Weakly 
detectable bands of Gata6 may be due to the presence of differentiated cells in ES cell 
cultures (Fig. 1f).   
rEF 
(E14.5) 
rESWIv 
3i-1 
rESWIv 
3i-5 
E9.5 
embryo 
Oct-4 
Fgf-4 
Rex-1 
Gata6 
ß-actin 
rNanog 
 
Fig. 2. Reverse transcription-PCR analysis for rat embryonic fibroblast cells at E14.5 (rEF; 
negative control for stem cell markers), rat embryos at E9.5 (positive control for Gata6), and 
two rat ES cell lines (rESWIv3i-1 and rESWIv3i-5). Both ES cell lines expressed stem cell 
markers, including Oct-4, rNanog, Fgf-4 and Rex-1 
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Furthermore, multipotency of the tentative ES cells (whether the cells can differentiate into 
endoderm, mesoderm, and ectoderm) should be confirmed. The tentative rESWIv3i-1 line 
(2.5 x 105 cells) has been subcutaneously transplanted into an adult male F344 nude rat. Five 
weeks after the transplntation, a tumor was observed (Fig. 3a), and its histological section 
was evaluated ater hematoxylin-eosin staining. As shown in Fig. 3b, the tumor was found to 
be a teratoma with various tissues including gut-like epithelium or hepatic cells (endoderm), 
bone, cartilage or muscle (mesoderm), and neural tissues (edctoderm). 
 
Marker gene  Primer sequence Product size 
forward 5’- GGGATGGCATACTGTGGAC-3’ 
Oct-4 
reverse 5’- CTTCCTCCACCCACTTCTC-3’ 
412 bp 
forward 5’- GCCCTGAGAAGAAAGAAGAG-3’ 
rNanog 
reverse 5’- CGTACTGCCCCATACTGGAA-3’ 
356 bp 
forward 5’- CGGGGTGTGGTGAGCATCTTC-3’ 
Fgf-4 
reverse 5’- CCTTCTTGGTCCGCCCGTTC-3’ 
202 bp 
forward 5’- TTCTTGCCAGGTTCTGGAAGC-3’ 
Rex-1 
reverse 5’- TTTCCCACACTCTGCACACAC-3’ 
297 bp 
forward 5’- TCATCACGACGGCTTGGACTG-3’ 
Gata6 
reverse 5’- GCCAGAGCACACCAAGAATCC-3’ 
467 bp 
forward 5’- CATGGCATTGTGATGGACT-3’ 
ß-actin 
reverse 5’- ACGGATGTCAACGTCACACT-3’ 
427 bp 
Table 1. Primers used for PCR amplification 
 
b a 
 
Fig. 3. Tumor observed 5 weeks after subcutaneous injection of rESWIv3i-1line ES cells into 
a nude rat (a), and histological section of the tumor stained with hematoxylin-eosin (b). The 
tumor was found to be a telatoma with various tissues including gut-like epithelium or 
hepatic cells (endoderm: bottom right), bone, cartilage or muscle (mesoderm: center), and 
neural tissues (ectoderm: upper right). Scale bar; 1-cm 
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3.3 Production of germline chimera rats by blastocyst injection 
To generate ES cell-derived chimeras, host blastocysts at E4.5 derived from Wistar females 
or Wistar x Dark-Agouti F1 females were microinjected with 10 ES cells each at passage 6 or 
8 (Fig. 4a and 4b). Briefly, using blunt-ended injection pipette with an outer diamether of 15 
µm, the zona pellucida of host blastocysts was penetrated by a piezo-pulse. The pipette tip 
was forwarded to inner cell mass (ICM) through thin junction area between the two 
trophoblastic cells (without any piezo force), and then the ES cells were deposited. 
Collapsed blastocysts (Fig. 4c) were re-blasturated 1 to 2 h after the microinjection, and 
allowed to develop to fetus (E15.5) or full-term pups in pseudopregnant Wistar recipients. 
All of the E15.5 fetuses (100%; Fig. 4d) and majority of the newborn pups (81.8 to 100%) 
were chimeric and expressed the venus gene (Table 2). The characteristics of the ES cells was 
successfully transmitted to their next generations in both lines (Fig. 5); Among 7 chimeras 
derived from passage-6 rESWIv3i-1 cells and developed to adult, three were female. Two of 
the 3 female chimeras transmitted the Venus gene through the germline (4/15 and 2/14, 
respectively). Among 5 chimeras derived from passage-8 rESWIv3i-5 cells and developed to 
adult, only one rat was female. This female chimera also transmitted the transgene to the 
next generations (1/26, two litters). The ability of the ES cells to participate in chemeras was 
still high (78.6 to 100%) at advanced passage numbers (17 or 18; Table 2). Overall efficiency 
of producing chimeric rats (50.3%, 94 chimeras/187 injected embryos) was higher than 8.2% 
(20/245) as reported in Buehr et al. (2008) and 11.0% (26/237) in Li et al. (2008). This higher 
efficiency of chimera rat production is probably due to the rat strain combination used for 
donor (ES cells) and host (blastocysts) and/or modification of culture medium. 
 
 
Fig. 4. Microinjection of 10 ES cells into a blastocoele of E4.5 blastocyst (a). Semi-bright, 
fluorescent image of venus-positive ES cells in the blastocyst (b). Collapsed blastocysts 
immediately after microinjection (c). Venus-positive fetal rat at E15.5 (d) 
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  No. (%) of embryos  No. (%) of fetus or pups 
Passage Developed Developed  Identified as 
Cell line 
number 
Injected 
to fetus to pups  
Analyzed 
chimera 
  6 17  13 (76.5) —  13   13 (100) 
 rESWIv  6 34 —  21 (61.8)  17   17 (100) 
 3i-1 17 28  17 (60.7) —  17   14 (82.4) 
 17 28 —  14 (50.0)  14   11 (78.6) 
  8 12   9 (75.0) —   9    9 (100) 
 rESWIv  8 13 —  11 (84.6)  11    9 (81.8) 
 3i-5 18 22   7 (31.8) —   7    7 (100) 
 18 33 —  14 (42.4)  14   14 (100) 
Table 2. Contribution of rat ES cells for chimera production 
 
rESWIv3i-1 rESWIv3i-5 
 
Fig. 5. Progeny test for germline transmission from rESWIv3i-1 or rESWIv3i-5-derived 
chimeric rats (half-green circle; female). Green circle and square indicate germline-
transmitted (venus-positive) females and males, respectively 
4. Transgenesis via rat ES cells 
Functional germline-competent rat ES cell lines have been established by applying 2i/3i 
culture system, and the minimal essential materials for conducting transgenic studies 
including reverse genetic approaches, are now ready for this rodents. In this section, the 
production efficiency of chimeric rats by blastocyst injection of ES cells electroporated with a 
humanized Kusabira-Orange (huKO) gene and the germline transmission of the huKO gene 
from the chimeras to next generation (Hirabayashi et al., 2010b; with a few additional data) 
are described. 
4.1 Electroporation of ES cells with foreign gene 
Rat ES cell lines were newly established from E4.5 blastocysts derived from Brown-Norway 
(BN) females (couplated with BN males), as described above, by applying 2i culture system. 
The culture medium used for establishment of ES cell lines from BN rats was in N2B27 
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medium supplemented with 2i (MEK inhibitor PD0325901, 1 µM; GSK3 inhibitor 
CHIR99021, 3 µM) and rat LIF (1,000 U/ml ESGRO). One of the established lines, named as 
rESBN2i-4, was derived from a male embryo, based on a PCR analysis using a primer set to 
detect the rat Sry gene. At passage 8, the ES cells in N2B27 medium supplemented with 10% 
FBS (1 x 106 cells/0.5 ml) were electroporated with 25 µg huKO gene (CAG/huKO-neo 
plasmid; 4.5 kb) using the Bio-Rad Genepulser-II apparatus at 800 V, 10 µF. The 
electroporated ES cells were plated into a 60 mm petri dish containing 3 ml of 2i medium + 
5% FBS (passage 9), and the next day the medium was changed to serum-free 2i medium. 
Two days after electroporation, 200 µg/ml G418 was added to the medium. The number of 
neomycin-resistant colonies (passage 10) was counted 8 days after electroporation (Fig. 6). 
The huKO-positive ES cells were passaged twice in G418-free medium. 
 
 
Fig. 6. Rat ES cell colonies stably expressing huKO gene, generated by electroporation, 
selection with neomycin, and the subsequent expansion. Bright field (a) and fluorescent 
image (b). Scale bars; 100-µm 
4.2 Production of G1 generation transgenic rats 
Host blastocysts derived from Wistar/ST or Wistar-Hannover females were microinjected 
with 10 each of the G418-resistant huKO-positive ES cells, and allowed to develop to full-
term in pseudopregnant Wistar recipients. As shown in Table 3, transfer of 116 and 97 
blastocysts resulted in 31 and 44 new-born offspring (26.7 and 45.4%), and 22 (70.9%; male 
12, female 10) and 34 (77.3%; male 15, female 17, not-identified 2) out of the offspring were 
judged as chimeras by their coat color, respectively (Fig, 7a). Using non-electroporated 
control ES cells, similar offspring rate (37.5%, 9/24) and chimera production efficiency 
(88.9%, 8/9) were obtained. Rat strain for host blastocysts may be a factor influencing the 
the overall efficiency of chimera production, due to different preference for full-term 
development. Some male chimeras (n=9) were coupled with wild-type Wistar females, 
resulting in the birth of total 118 G1 offspring. Germline transmission of the CAG/huKO-
neo gene was confirmed in 6 out of 25 G1 offspring (Fig. 7b and 7c) derived from 1 chimeric 
male with >95% brown-colored coat. Thus, integration of exogenous DNA into rat ES cells 
did not affect the production efficiency of chimera offspring. In addition, the result 
described in this section (slightly expanded from Hirabayashi et al., 2010b) achieved the first 
successful production of transgenic rats via electroporated ES cells, followed by Kawamata 
& Ochiya (2010) and Tong et al. (2010). 
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  No. (%) of embryos  No. (%) [%]* of pups 
Transfected
DNA 
Rat strains for 
host blastocysts 
Injected 
Developed 
to pups 
 Identified as chimera 
Wistar/ST   116   31 (26.7)     22 (70.9) [19.0] 
CAG/huKO 
Wistar-Hannover    97   44 (45.4)     34 (77.3) [35.1] 
Control 
(No DNA) 
Wistar/ST    24  9 (37.5)      8 (88.9) [33.3] 
Table 3. Effect of electroporation of rESBN2i-4 cells with huKO gene on the production of 
chimeric rats.  
* Calculated from injected embryos 
 
 
Fig. 7. Chimeric rats with different contribution of brown-colored coat at G0 generation, 17-
days old (a), a huKO transgenic newborn young at G1 generation, 3-days old (b), and a huKO 
transgenic offspring (brown-colored) with huKO-negative littermates, 3-weeks old (c)    
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5. Conclusion 
Functional germline-competent rat ES cell lines have been first reported in 2008 December 
(Buehr et al., 2008; Li et al., 2008). The difficulty in establishing rat ES cells until those time 
has been overcome by using a few inhibitors for FGF receptor, MEK and GSK3 in 
differentiation-related signaling pathways. Reproducibility of this 2i/3i culture system in 
establishing rat ES cells has been proved by two independent groups (Hirabayashi et al., 
2010a; Kawamata & Ochiya, 2010) and both groups successfully applied their own cell lines 
for producing transgenic rats (Hirabayashi et al., 2010b; Kawamata & Ochiya, 2010). Very 
recently, the production of p53 gene knock-out rats via homologous recombination in ES 
cells has been reported by Tong et al. (2010). Although knockout rats were also successfully 
produced by ENU-induced, SB transposon-tagged, or ZFNs-based mutagenesis, such 
successes may not give impacts on creating rat models for human diseases due to limitation 
in genome modification by these technologies. Thus, the homologous recombination-based 
gene targeting technology in „ES cells“ would provide a practical breakthrough for wide 
range of biomedical research in the laboratory rats. 
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